Previous 10 | Next 10 |
Healthcare equipment maker Nevro Corp. ( NYSE: NVRO ) announced Monday that the recent decision by UnitedHealthcare ( UNH ) to limit coverage for spinal cord stimulation (SCS) devices is unlikely to have a material impact on its future revenue. NVRO, the maker of the S...
Nevro Comments on UnitedHealthcare Medical Coverage Policy Update PR Newswire REDWOOD CITY, Calif. , Oct. 10, 2022 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solution...
Nevro to Report Third Quarter 2022 Financial Results PR Newswire Company to Host Conference Call on Wednesday, November 2, 2022 at 1:30 pm PT / 4:30 pm ET REDWOOD CITY, Calif. , Oct. 5, 2022 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO)...
Medical device company Nevro ( NYSE: NVRO ) on Tuesday said the U.S. FDA had approved its manufacturing operations in Costa Rica for the production of its spinal cord stimulation systems for the treatment of chronic pain. The new facility, located in Alajuela, Costa Rica, ...
Nevro Announces FDA Approval of Costa Rica Manufacturing Operations PR Newswire REDWOOD CITY, Calif. , Oct. 4, 2022 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions fo...
Nevro Announces American Association of Clinical Endocrinology Clinical Practice Guideline Has Been Updated to Include High-Frequency 10 kHz Spinal Cord Stimulation to Treat Painful Diabetic Neuropathy PR Newswire REDWOOD CITY, Calif. , Oct. 3, 2022 /PRNe...
Summary Nevro Corp remains an attractive play in chronic non-specific lower back pain and diabetic peripheral neuropathy. It came in with a strong set of quarterly numbers last period demonstrating robust top-line growth. Shares are trading in line with our estimate of fair va...
Nevro Announces Multiple Positive Coverage Updates for the Treatment of Painful Diabetic Neuropathy PR Newswire Aetna Updates Spinal Cord Stimulation Coverage Policy to Include Painful Diabetic Neuropathy Effective Immediately Medicare Administrative Carr...
The following slide deck was published by Nevro Corp. in conjunction with this event. For further details see: Nevro (NVRO) Presents At 42nd Annual Global I Growth Conference - Slideshow
Nevro Announces Participation In Upcoming Investor Conferences PR Newswire REDWOOD CITY, Calif. , Aug. 9, 2022 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the...
News, Short Squeeze, Breakout and More Instantly...
Nevro to Report Second-Quarter 2024 Financial Results and Host Earnings Conference Call on August 6, 2024 PR Newswire REDWOOD CITY, Calif. , July 9, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-chan...
Nevro to Present at Truist Securities MedTech Conference PR Newswire REDWOOD CITY, Calif. , June 11 , 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chr...
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 PR Newswire REDWOOD CITY, Calif. , May 24, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the trea...